Globus Medical (GMED) Price & Analysis

Compare

880 Followers

GMED Stock Chart & Stats

Day’s Range― - ―

52-Week Range$51.79 - $94.93

Previous CloseN/A

Volume442.39K

Average Volume (3M)1.51M

Market Cap

$8.36B

Enterprise Value$7.95B

Total Cash (Recent Filing)$229.45M

Total Debt (Recent Filing)$121.10M

Price to Earnings (P/E)23.7

Beta0.92

Next Earnings

Nov 11, 2025

EPS Estimate

0.78

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.86

Shares Outstanding112,620,210

10 Day Avg. Volume1,132,414

30 Day Avg. Volume1,507,630

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.95

Enterprise Value/Revenue3.03

Enterprise Value/Gross Profit4.74

Enterprise Value/Ebitda10.86

Forecast

1Y Price Target

$83.00

Price Target Upside34.94% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering13

Bulls Say, Bears Say

Bulls Say

EarningsQ2 EPS was $0.86 well ahead of consensus as Nevro dilution was less than feared.

Product InnovationRecently, GMED received FDA clearance for Excelsius XR, a head-mounted augmented reality navigation headset.

Revenue PerformanceGMED delivered 3.6% year-over-year organic growth in Q2, which was in line with the pre-announcement and ahead of initial estimates and consensus.

Bears Say

Competitive ConcernsThe CEO transition raises questions about the stability and future direction of the company, especially with the competitive nature of the spine industry.

Guidance ChallengesThe company faces a challenging setup due to increasingly difficult comparisons and the need to reset guidance, affecting its stock rating.

Tech Sales PerformanceEnabling tech sales were up sequentially but missed Street by 7%.

Globus Medical News

Globus Medical secures jury verdict in patent litigation against Life Spine

Globus Medical (GMED) announced that a Delaware jury has returned a verdict in favor of Globus in its...

17h ago

GMED

Globus Medical price target lowered to $66 from $76 at Wells Fargo

Wells Fargo lowered the firm’s price target on Globus Medical (GMED) to $66 from $76 and keeps an...

21d ago

GMED

Globus Medical reports Q2 non-GAAP EPS 86c, consensus 75c

Reports Q2 revenue $745.3M, consensus $742.73M. “Q2 results were led by our US Spine business, growing 5.7%, as...

22d ago

GMED

Globus Medical sees FY25 non-GAAP EPS $3.00-$3.30, consensus $3.16

Sees FY25 revenue $2.8B-$2.9B, consensus $2.85B. Published first on TheFly – the ultimate source for real-time, market-moving breaking...

22d ago

GMED

Globus Medical’s Earnings Call Highlights Robust Growth and Strategic Advances

Globus Medical (($GMED)) has held its Q2 earnings call. Read on for the main highlights of the call....

17d ago

GMED

Globus Medical Reports Strong Q2 2025 Growth

Globus Medical ( ($GMED) ) has released its Q2 earnings. Here is a breakdown of the information Globus...

21d ago

GMED

Is GMED a Buy, Before Earnings?

Globus Medical (GMED) is scheduled to report 2nd quarter earnings on 08/07/2025, after the market closes. Regarding Q2...

24d ago

GMED

Globus Medical price target lowered to $90 from $97 at Canaccord

Canaccord lowered the firm’s price target on Globus Medical (GMED) to $90 from $97 and keeps a Buy...

1M ago

GMED

Hold Rating on Globus Medical Amid Management Changes and Spine Business Concerns

BTIG analyst Ryan Zimmerman has reiterated their neutral stance on GMED stock, giving a Hold rating yesterday. Ryan...

1M ago

GMED

Optimistic Outlook on Globus Medical: Strategic Changes and Positive Q2 Performance Drive Buy Rating

Morgan Stanley analyst Patrick Wood has maintained their bullish stance on GMED stock, giving a Buy rating yesterday....

1M ago

GMED

Globus Medical price target lowered to $88 from $90 at Jefferies

Jefferies lowered the firm’s price target on Globus Medical (GMED) to $88 from $90 and keeps a Buy...

1M ago

GMED

Roth MKM medical technology analyst holds analyst/industry conference call

Medical Technology Analyst Wittes, along with Dr. Doug Unis, Founder & CMO of Monogram Technologies (MGRM) discuss the...

1M ago

JNJ

SYK

Verizon reports Q2 beat, Block to join S&P 500: Morning Buzz

The major averages were broadly higher near noon, kicking off the week in positive territory amid optimism over...

1M ago

Roth bullish on Globus Medical amid CEO Transition, solid pre-reported results

Roth Capital analyst Jason Wittes notes that it was announced that Globus Medical (GMED) CEO Daniel Scavilla has...

1M ago

GMED

XRAY

GMED FAQ

What was Globus Medical’s price range in the past 12 months?

Globus Medical lowest stock price was $51.79 and its highest was $94.93 in the past 12 months.

What is Globus Medical’s market cap?

Globus Medical’s market cap is $8.36B.

When is Globus Medical’s upcoming earnings report date?

Globus Medical’s upcoming earnings report date is Nov 11, 2025 which is in 74 days.

How were Globus Medical’s earnings last quarter?

Globus Medical released its earnings results on Aug 07, 2025. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.753 by $0.107.

Is Globus Medical overvalued?

According to Wall Street analysts Globus Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Globus Medical pay dividends?

Globus Medical does not currently pay dividends.

What is Globus Medical’s EPS estimate?

Globus Medical’s EPS estimate is 0.78.

How many shares outstanding does Globus Medical have?

Globus Medical has 112,620,210 shares outstanding.

What happened to Globus Medical’s price movement after its last earnings report?

Globus Medical reported an EPS of $0.86 in its last earnings report, beating expectations of $0.753. Following the earnings report the stock price went up 8.471%.

Which hedge fund is a major shareholder of Globus Medical?

Currently, no hedge funds are holding shares in GMED

Globus Medical Stock Smart Score

Neutral

Fundamentals

Return on Equity

8.62%

Trailing 12-Months

Asset Growth

-0.65%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Globus Medical

Globus Medical (GMED) is a leading medical device company focused on developing innovative solutions for the treatment of spinal disorders. Founded in 2003 and headquartered in Audubon, Pennsylvania, the company specializes in spinal implant technologies and instruments that improve patient outcomes. GMED's core product offerings include spinal fusion devices, minimally invasive surgical products, and advanced technologies for spinal surgery, addressing the needs of neurosurgeons and orthopedic surgeons worldwide.

Globus Medical (GMED) Earnings & Revenues

Historic Earnings Reports

GMED Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call depicts a strong quarter for Globus Medical, highlighted by significant revenue growth, a successful integration of Nevro, and continued innovation. Despite some challenges in international markets and lingering supply chain issues, the overall performance and future outlook appear positive.View all GMED earnings summaries

GMED Net sales Breakdown

92.34% Musculoskeletal Solutions

7.66% Enabling Technologies

GMED Stock 12 Month Forecast

Average Price Target

$83.00

▲(34.94% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"51":"$51","65":"$65","79":"$79","93":"$93","107":"$107"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":106,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$106.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":83,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$83.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$65.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[51,65,79,93,107],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.64,56.744615384615386,60.84923076923077,64.95384615384616,69.05846153846154,73.16307692307693,77.2676923076923,81.37230769230769,85.47692307692307,89.58153846153846,93.68615384615384,97.79076923076923,101.89538461538461,{"y":106,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.64,54.97538461538461,57.31076923076923,59.646153846153844,61.98153846153846,64.31692307692308,66.65230769230769,68.9876923076923,71.32307692307693,73.65846153846154,75.99384615384615,78.32923076923078,80.66461538461539,{"y":83,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.64,53.59076923076923,54.541538461538465,55.49230769230769,56.44307692307692,57.393846153846155,58.34461538461539,59.29538461538461,60.246153846153845,61.19692307692308,62.14769230769231,63.098461538461535,64.04923076923077,{"y":65,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":70.1,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.7,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.4,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.88,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.9,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.71,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.72,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.32,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.39,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.11,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.64,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >